Insider Transactions Reported by 20 Insiders of HOOKIPA Pharma Inc.

Symbol: HOOK on OTC
Location: New York, NY

Quick Takeaways

HOOK - HOOKIPA Pharma Inc. has 20 insiders with reported activity on this page.
Net insider value flow over the last year: -$60,046.
Recent transaction rows are available for direct filing-level review.

What Changed

Buy value: ; sell value: $60,046.
Net share flow: -67,957.

Why This Matters

This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.

Official SEC Source

Filed on Form 4

Issuer insider activity is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Insider trading overview

Last 12 months

Net insider flow leans to selling over the last 12 months. Net value: -$60,046.

Buys

Shares: 0

Insiders: 0

Sells

$60,046

Shares: 67,957

Insiders: 2

Net

-$60,046

Shares: -67,957

Insiders: -2

Window (months)	Sell shares	Buy $	Sell $	Net $
0-3	0	$0	$0	$0
3-6	0	$0	$0	$0
6-9	67,957	$0	$60,046	-$60,046
9-12	0	$0	$0	$0

HOOKIPA Pharma Inc. executives and other stock owners filed with the SEC include:

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Valuation	Report Date
GILEAD SCIENCES, INC.	10%+ Owner	$13,600,612			Mixed	20 Dec 2023
Jorn Aldag	Chief Executive Officer, Director	$52,165			Mixed	15 Apr 2024
Mary Theresa Coelho	EVP and CFO, Director	$51,764	-$12,520	-19%	Filing P/S	22 Jul 2025
Malte Peters	Chief Executive Officer, Director	$44,656	-$47,526	-52%	Filing P/S	19 Aug 2025
Reinhard Kandera	Chief Financial Officer, Director	$31,242			Filing P/S	15 Apr 2024
Katia Schlienger	Chief Medical Officer	$943			Mixed	14 Apr 2023
David Ross Kaufman	Director				Mixed	17 Jun 2024
Jean-Charles Soria	Director				Mixed	01 Jun 2021
Igor Matushansky	Chief Medical Officer				Mixed	30 Jun 2022
Christine D. Baker	Chief Operating Officer				Mixed	14 Apr 2023
Graziano Seghezzi	Director				Mixed	01 Jun 2021
Michael Aaron Kelly	Director				Mixed	30 Jun 2022
Julie O'Neill	Director				Mixed	17 Jun 2024
Jan van de Winkel	Director				Mixed	17 Jun 2024
Christoph Lengauer	Director				Mixed	01 Jun 2021
Sean A. Cassidy	Director				Mixed	22 Jul 2024
Mark Winderlich	Chief Development Officer				Mixed	15 Apr 2024
Timothy P. Reilly	Director				Mixed	17 Jun 2024
Roman Necina	Chief Operations Officer				Mixed	15 Apr 2024
Klaus Orlinger	Chief Scientific Officer				Mixed	15 Apr 2024

Top shareholders of HOOKIPA Pharma Inc. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
GILEAD SCIENCES, INC.	3/4/5	10%+ Owner	— class O/S missing	18,759,465	$13,600,612	—	20 Dec 2023	3/4/5
EcoR1 Capital, LLC	13D/G	—	4%	388,861	$326,643	$0	31 Dec 2024	13D/G
SOFINNOVA CAPITAL VI FCPR	13D/G	—	2.6%	314,259	$263,978	$0	14 Feb 2025	13D/G
Jorn Aldag	3/4/5	Chief Executive Officer, Director	— mixed-class rows	1,043,352 mixed-class rows	$52,165	—	15 Apr 2024	3/4/5
Mary Theresa Coelho	3/4/5	EVP and CFO, Director	0.47%	56,266	$51,764	-$12,520	22 Jul 2025	3/4/5
Malte Peters	3/4/5	Chief Executive Officer, Director	0.45%	54,347	$44,656	-$47,526	19 Aug 2025	3/4/5
Reinhard Kandera	3/4/5	Chief Financial Officer, Director	— mixed-class rows	449,292 mixed-class rows	$31,242	—	15 Apr 2024	3/4/5
Katia Schlienger	3/4/5	Chief Medical Officer	— mixed-class rows	185,300 mixed-class rows	$943	—	14 Apr 2023	3/4/5
Klaus Orlinger	3/4/5	Chief Scientific Officer	— class O/S missing	367,300	—	—	15 Apr 2024	3/4/5
Roman Necina	3/4/5	Chief Operations Officer	— class O/S missing	367,300	—	—	15 Apr 2024	3/4/5
Christine D. Baker	3/4/5	Chief Operating Officer	— class O/S missing	275,800	—	—	14 Apr 2023	3/4/5
Jan van de Winkel	3/4/5	Director	— class O/S missing	98,000	—	—	17 Jun 2024	3/4/5
Igor Matushansky	3/4/5	Chief Medical Officer	— class O/S missing	92,950	—	—	30 Jun 2022	3/4/5
Mark Winderlich	3/4/5	Chief Development Officer	— class O/S missing	50,000	—	—	15 Apr 2024	3/4/5
David Ross Kaufman	3/4/5	Director	— class O/S missing	49,000	—	—	17 Jun 2024	3/4/5
Julie O'Neill	3/4/5	Director	— class O/S missing	49,000	—	—	17 Jun 2024	3/4/5
Timothy P. Reilly	3/4/5	Director	— class O/S missing	49,000	—	—	17 Jun 2024	3/4/5
Michael Aaron Kelly	3/4/5	Director	— class O/S missing	20,000	—	—	30 Jun 2022	3/4/5
Sean A. Cassidy	3/4/5	Director	— class O/S missing	9,800	—	—	22 Jul 2024	3/4/5
Christoph Lengauer	3/4/5	Director	— class O/S missing	9,600	—	—	01 Jun 2021	3/4/5
Graziano Seghezzi	3/4/5	Director	— class O/S missing	9,600	—	—	01 Jun 2021	3/4/5
Jean-Charles Soria	3/4/5	Director	— class O/S missing	9,600	—	—	01 Jun 2021	3/4/5

Recent Insider Transactions by Companies or Individuals for HOOKIPA Pharma Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership
Malte Peters	HOOK	Common Stock	Sale	-31.7%	$20,684	$0.8217	-25,172	54,347	19 Aug 2025	Direct
Malte Peters	HOOK	Common Stock	Sale	-26.8%	$26,842	$0.9200	-29,176	79,519	22 Jul 2025	Direct
Mary Theresa Coelho	HOOK	Common Stock	Sale	-19.5%	$12,520	$0.9200	-13,609	56,266	22 Jul 2025	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.